On July 10, the Department of Justice (DOJ) announced a nearly $410 million settlement with Rite Aid Corporation to resolve allegations that Rite Aid and its affiliates ignored red flags and knowingly dispensed unlawful controlled substances in violation of the False Claims Act (FCA) and Controlled Substances Act (CSA). Continue Reading Rite Aid and OptumRx Settlements Highlight Enforcement Focus on Pharmacy Corresponding Responsibility for Dispensing Controlled Substances
Theresa Androff
Drawing on her experience at the Florida Office of the Attorney General, Theresa Androff represents clients facing government and internal investigations, with a particular focus on fraud and abuse matters in the healthcare industry including drug diversions and related compliance under the Controlled Substances Act and the Food, Drug and Cosmetics Act. She works closely with companies on compliance and investigations alleging violations of federal and state Stark Laws, the Anti-Kickback Statute, and the False Claims Act.
False Claims Act Settlements to Know from Q1 2024
Despite the recent downward trend in DOJ healthcare industry settlements, the first quarter of 2024 saw many noteworthy False Claims Act (FCA) and civil healthcare fraud settlements related to alleged kickbacks, medically unnecessary services and equipment, pharmaceutical issues and Controlled Substances Act violations.Continue Reading False Claims Act Settlements to Know from Q1 2024